International Pharmaceutical Company
International Pharmaceutical Company is a UAE-based healthcare distributor established in 2007, holding exclusive and non-exclusive distribution agreements with European and U.S. manufacturers to supply pharmaceuticals, medical devices, and related healthcare products to providers across the UAE and GCC.
- Company typePrivate
- Founded2007
- HeadquartersAjman, United Arab Emirates
- Headcount51–100
- GTM typeB2B
- OfferingServices
What International Pharmaceutical Company does
International Pharmaceutical Company is a privately held healthcare distribution company established in 2007 and headquartered in the Al Jurf Industrial Area of Ajman, United Arab Emirates. It operates as a diversified distributor of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements, serving healthcare providers, pharmacies, and medical facilities across the UAE and broader GCC territories. The company's core commercial asset is a portfolio of exclusive distributorship agreements with European and U.S.-based manufacturers — including Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer, and Turkuaz — alongside non-exclusive distribution arrangements with multinationals such as Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma.
The underlying operating capability is a GSDP-compliant storage and distribution infrastructure that supports quality, safety, and efficacy requirements across the supply chain. There is no proprietary technology platform, software product, or digital offering described in the available material; the business model is fundamentally a traditional B2B distribution franchise with sales-led engagement of institutional healthcare buyers.
Revenue mechanics are based on transactional resale of distributed products under exclusive and non-exclusive rights. Pricing is not publicly disclosed and the company operates as a private entity with no disclosed ownership, funding history, leadership team, or financial statements. The firm employs approximately 90 staff based at its Ajman headquarters. The primary data gaps are revenue, profitability, customer concentration by principal or channel, and any plans for digital or technology-led expansion.
International Pharmaceutical Company firmographics
Firmographics- Name
- International Pharmaceutical Company
- Legal name
- International Pharmaceuticals Company
- Website
- https://intl-pharma.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- International Pharmaceutical Company is a UAE-based healthcare distributor established in 2007, holding exclusive and non-exclusive distribution agreements with European and U.S. manufacturers to supply pharmaceuticals, medical devices, and related healthcare products to providers across the UAE and GCC.
- Ownership category
- akta.pro rank
International Pharmaceutical Company industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industry
- Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)
Keywords
Where International Pharmaceutical Company is headquartered
LocationHeadquarters
- HQ city
- Ajman
- HQ country
- United Arab Emirates
- HQ region
- Middle East
Offices1 record
Markets served
International Pharmaceutical Company business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Distribution: International Pharmaceutical Company generates revenue through the distribution of pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. They acquire exclusive and non-exclusive distribution rights from pharmaceutical manufacturers and resell to healthcare providers in the UAE and GCC markets.
Go-to-market motion1 record
Distribution channels1 record
International Pharmaceutical Company product offering
Product offeringCore offering
International Pharmaceuticals Co. distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements across the UAE and GCC. The company serves as the exclusive regional distributor for several international healthcare brands, sourcing products from manufacturers and supplying them to local healthcare providers and pharmacies.
Product overview
International Pharmaceutical Company operates as a diversified healthcare distribution provider offering a comprehensive portfolio of pharmaceutical and healthcare products. The company distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements. The distribution model includes exclusive distributorship agreements with European and U.S.-based companies (Qualiphar, Anika Therapeutics Inc, ORZAX, Gifrer and Turkuaz) and serves as a distributor for multinational companies including Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma across the UAE and GCC territories. The product portfolio emphasizes innovative and high-quality solutions delivered through Good Storage and Distribution Practices (GSDP).
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Distribution of pharmaceutical products sourced from international manufacturers including Qualiphar, Sanofi Aventis, Merck Sonoro, Meda Pharma, and Novartis Pharma, supplied to pharmacies, hospitals, and healthcare providers across the UAE and GCC.
- Medical Device Distribution Distribution of medical devices, including home monitoring devices, sourced from manufacturers such as Anika Therapeutics Inc., supplied to healthcare facilities in the UAE and GCC.
- Laboratory Reagent Distribution Distribution of laboratory reagents for clinical and research laboratories, supplied to medical laboratories and diagnostic facilities across the UAE and GCC.
- Skin and Beauty Care Products Distribution Distribution of skin and beauty care products sourced from brands including Gifrer (France) and ORZAX (Turkey), supplied to pharmacies and consumer health channels in the UAE and GCC.
- Dietary Supplement Distribution Distribution of dietary supplements sourced from international brands including Turkuaz (Turkey), supplied to pharmacies and consumer health retailers in the UAE and GCC.
Companies that use International Pharmaceutical Company
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles1 record
International Pharmaceutical Company technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
International Pharmaceutical Company partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core.
- QualipharcoreEuropean-based pharmaceutical/ healthcare company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
- Anika Therapeutics InccoreU.S.-based medical/ pharmaceutical company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
- ORZAXcoreEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
- GifrercoreEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
- TurkuazcoreEuropean-based company with exclusive distributorship agreement held by International Pharmaceutical Company for UAE and GCC territories.
- Sanofi AventiscoreRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.
- Merck SonorocoreMultinational medical products company for whom International Pharmaceutical Company serves as distributor in the UAE market.
- Meda PharmacoreRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.
- Novartis PharmacoreRenowned multinational pharmaceutical company for whom International Pharmaceutical Company serves as distributor in the UAE market.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
International Pharmaceutical Company competitors and assessment
Company assessmentDirect peers
- Global Pharma Healthcare: UAE-based pharmaceutical distributor operating in the same UAE/GCC region. Comparable direct peer distributing pharmaceutical and healthcare products to regional providers.
- Neopharma: UAE-based pharmaceutical manufacturer with regional distribution across MENA markets. Directly comparable as a UAE-rooted pharma company distributing branded and generic products to healthcare providers in the same GCC footprint.
- Julphar (Gulf Pharmaceutical Industries): UAE-headquartered pharmaceutical manufacturer and distributor operating across the GCC and MENA. Comparable to International Pharmaceutical Company as a regional pharma distributor serving similar healthcare-provider and pharmacy customers in the same core UAE/GCC geography.
- Hikma Pharmaceuticals: Jordan-headquartered multinational with one of the largest commercial footprints across MENA. Comparable as a regional pharma manufacturer-distributor serving GCC healthcare providers, though at significantly larger scale.
- Zahrawi Medical: UAE-based medical devices and pharmaceutical distributor serving hospitals and clinics across the GCC. Comparable as a UAE-anchored specialty healthcare distributor with a similar product breadth across devices and pharmaceuticals.
Regional players
- Tabuk Pharmaceuticals: Saudi Arabia-based pharmaceutical manufacturer and distributor with strong MENA presence. Comparable regional pharma distributor serving GCC healthcare providers, primarily anchored in Saudi Arabia rather than UAE.
- Cigalah Group: Saudi-based pharmaceutical and healthcare distributor serving MENA. Comparable as a regional pharma distribution peer operating primarily from Saudi Arabia into the broader GCC market.
- SPIMACO: Saudi-based pharmaceutical manufacturer and distributor operating across MENA. Comparable regional peer distributing branded and specialty pharma to healthcare providers, primarily from a Saudi rather than UAE base.
- Tamer Group: Saudi Arabia-based healthcare distribution and manufacturing group with broad pharma and consumer health portfolio. Comparable as a regional GCC healthcare distributor, primarily Saudi-anchored.
Broad incumbents
- Bayer Middle East: Multinational pharma and consumer health major with regional headquarters serving the Middle East. Comparable as a broad incumbent that distributes pharmaceuticals and consumer health products across the same GCC region through its own regional operations.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
International Pharmaceutical Company social profiles
Digital presenceInternational Pharmaceutical Company compliance and trust
Trust signalCompliance1 record
International Pharmaceutical Company financial estimates
Financial estimateRevenue estimate
Valuation estimate
International Pharmaceutical Company leadership team
Management profileNumber of profiles
International Pharmaceutical Company funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
International Pharmaceutical Company M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about International Pharmaceutical Company
What does International Pharmaceutical Company do?
International Pharmaceuticals Co. distributes pharmaceuticals, medical devices, laboratory reagents, skin and beauty care products, home monitoring devices, and dietary supplements across the UAE and GCC. The company serves as the exclusive regional distributor for several international healthcare brands, sourcing products from manufacturers and supplying them to local healthcare providers and pharmacies.
Is International Pharmaceutical Company a public or private company?
International Pharmaceutical Company is a private company. It is classified as unknown and is currently operating.
When was International Pharmaceutical Company founded?
International Pharmaceutical Company was founded in 2007. It employs 51 to 100 people.
Where is International Pharmaceutical Company based?
International Pharmaceutical Company is headquartered in Ajman, United Arab Emirates, in the Middle East region.
How does International Pharmaceutical Company make money?
One revenue line is on record: pharmaceutical Distribution.
Who are International Pharmaceutical Company's main competitors?
Direct peers on record are Global Pharma Healthcare, Neopharma, Julphar (Gulf Pharmaceutical Industries), Hikma Pharmaceuticals and Zahrawi Medical. Regional players are Tabuk Pharmaceuticals, Cigalah Group, SPIMACO and Tamer Group. Bayer Middle East is listed as a broad incumbent.
Does International Pharmaceutical Company have an API?
No public API is recorded for International Pharmaceutical Company.
What industry is International Pharmaceutical Company in?
International Pharmaceutical Company's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.